Beats / 13 priced constituents
biopharma
An equal-weight index of the priced names on this beat, rebuilt every Friday from the constituents that were actually in it.
108.7-8.4%base 100 · to 2026-09-11
This week
Up most
- Zealand Pharma0.0%
- Eli Lilly-2.9%
- Altimmune-4.4%
- Equillium, Inc.-4.5%
- Denali Therapeutics-5.3%
Down most
- Neumora Therapeutics-20.6%
- Structure Therapeutics-18.3%
- Amgen-13.7%
- BioAge Labs-11.5%
- Viking Therapeutics-8.3%
What happened
Nothing logged on biopharma in the last 30 days.
Dated ahead
| Date | Company | Period | Firmness |
|---|---|---|---|
| 2026-09-30 | Novo Nordisk NVO | 2026-09-30 | confirmed |
| 2026-10-26 | Viking Therapeutics VKTX | 2026-Q3 | expected |
| 2026-10-26 | Novo Nordisk NVO | 2026-10-26 | expected |
| 2026-10-27 | Amgen AMGN | 2026-10-27 | expected |
| 2026-10-27 | Eli Lilly LLY | 2026-10-27 | expected |
| 2026-10-27 | Roche ROG.SW | 2026-10-27 | expected |
| 2026-11-04 | Amgen AMGN | 2026-Q3 | expected |
| 2026-11-04 | Eli Lilly LLY | 2026-Q3 | expected |
| 2026-11-04 | Vertex Pharmaceuticals VRTX | 2026-Q3 | expected |
| 2026-11-06 | Denali Therapeutics DNLI | 2026-Q3 | expected |
| 2026-11-09 | BioAge Labs BIOA | 2026-Q3 | expected |
| 2026-11-09 | Structure Therapeutics GPCR | 2026-Q3 | expected |
| 2026-11-09 | Unity Biotechnology UBX | 2026-Q3 | expected |
| 2026-11-11 | Neumora Therapeutics NMRA | 2026-Q3 | expected |